首页|基于生物信息学分析三阴性乳腺癌的差异表达基因和药物靶点挖掘

基于生物信息学分析三阴性乳腺癌的差异表达基因和药物靶点挖掘

扫码查看
本文通过对美国国家生物技术信息中心的基因表达数据库(GEO)、肿瘤基因组数据库(TCGA)等数据库的乳腺癌数据进行生物学分析,筛选三阴性乳腺癌中相较于其他亚型差异表达的基因,探索三阴性乳腺癌这一亚型的基因表达层面的特征,从而根据其特征进行药物靶点的挖掘,并为三阴性乳腺癌的鉴别、预后提供一定的借鉴.通过生信分析,显示三阴性乳腺癌在细胞周期、雌激素信号通路等过程中有特征性的表现.筛选出的10个枢纽基因,可以较好地预测和诊断三阴性乳腺癌.通过药物靶点发掘,提示pyrazolanthrone、alvocidib等是有潜力的药物研发方向.
Effects of astragalus polysaccharide on proliferation and invasion of triple negative breast cancer cells
Through biological analysis of breast cancer data in gene expression omnibus(GEO),The Cancer Genome Atlas(TCGA)and other databases,this study screened the differentially expressed genes in triple-negative breast cancer compared with other breast cancer subtypes,so as to mine drug targets according to its characteristics and provide some reference for the identification and prognosis of triple-negative breast cancer.Based on the analysis of bio-informatics,it showed that triple negative breast cancer has characteristic manifestations in the process of cell cycle and estrogen signaling pathway.The screened 10 hub genes can better predict and diagnose triple negative breast cancer.The drug targets exploring rusults suggest that pyrazolanthrone,alvocidib and so on are potential drugs which have research and development value.

triple negative breast cancerbioinformaticsdifferential genedrug target

李岩、王兴河

展开 >

首都医科大学附属北京世纪坛医院药物Ⅰ期临床试验研究室,北京 100038

三阴性乳腺癌 生物信息学 差异基因 药物靶点

2024

中国临床药理学杂志
中国药学会

中国临床药理学杂志

CSTPCD北大核心
影响因子:1.91
ISSN:1001-6821
年,卷(期):2024.40(2)
  • 6